Skip to main content

MetLife Investment Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in TNGX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$1,269,718
+$740,847 QoQ
Shares Held
60,694
+1.7% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. TNGX ranks #55 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNGX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,269,718 60,694
2025-12-31 $528,871 59,692
2025-09-30 $400,898 47,726
2025-06-30 $244,357 47,726
2024-12-31 $60,659 19,631
2024-09-30 $217,632 28,264
2024-06-30 $242,505 28,264
2024-03-31 $204,693 25,780
2023-12-31 $255,222 25,780
2023-09-30 $290,282 25,780
2023-06-30 $85,589 25,780
2023-03-31 $101,831 25,780
2022-12-31 $186,905 25,780
2022-06-30 $129,734 28,639